{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "regularMarketChangePercent": -0.24479432, "regularMarketPrice": 81.5, "exchange": "TWO", "shortName": "PBI", "longName": "Pharmosa Biopharm Inc.", "messageBoardId": "finmb_638971796", "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "tw_market", "marketState": "POSTPOST", "esgPopulated": false, "sharesOutstanding": 110934000, "bookValue": 6.861, "fiftyDayAverage": 82.268, "fiftyDayAverageChange": -0.76799774, "fiftyDayAverageChangePercent": -0.009335316, "twoHundredDayAverage": 59.40486, "twoHundredDayAverageChange": 22.095139, "twoHundredDayAverageChangePercent": 0.3719416, "marketCap": 9041121280, "priceToBook": 11.878735, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1645491600000, "priceHint": 2, "regularMarketChange": -0.19999695, "regularMarketTime": 1684133887, "regularMarketDayHigh": 82.5, "regularMarketDayRange": "81.2 - 82.5", "regularMarketDayLow": 81.2, "regularMarketVolume": 141935, "regularMarketPreviousClose": 81.7, "bid": 81.2, "ask": 81.8, "fullExchangeName": "Taipei Exchange", "financialCurrency": "TWD", "regularMarketOpen": 81.7, "averageDailyVolume3Month": 454474, "averageDailyVolume10Day": 336216, "fiftyTwoWeekLowChange": 50.5, "fiftyTwoWeekLowChangePercent": 1.6290323, "fiftyTwoWeekRange": "31.0 - 95.6", "fiftyTwoWeekHighChange": -14.099998, "fiftyTwoWeekHighChangePercent": -0.14748953, "fiftyTwoWeekLow": 31.0, "fiftyTwoWeekHigh": 95.6, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.68, "symbol": "6875.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 66, Sanchong Road", "address2": "3rd Floor - 3 Nangang District", "city": "Taipei City", "zip": "11502", "country": "Taiwan", "phone": "886 2 2782 7561", "website": "https://www.pharmosa.com.tw", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It is developing L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension, pulmonary hypertension associated with interstitial lung disease, and chronic thromboembolic pulmonary hypertension; L608, an inhalation/device combination for the treatment of pulmonary vascular disease; and L220, an injection/device combination for the treatment of peripheral vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei City, Taiwan.", "fullTimeEmployees": 39, "companyOfficers": [{"maxAge": 1, "name": "Dr. Pei  Ken Ph.D.", "title": "Pres, GM & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Winny  Yang", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hui-An  Pao", "title": "VP of Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Ru-Yun  Lin M.B.A.", "age": 56, "title": "VP of Admin.", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}